Eric G. Orlinsky

Eric G. Orlinsky
Primary Office
Experience

Private Equity/Venture Capital

  • Represented Patriot Capital in their investment of subordinated debt and equity in support of Guardian Capital Partners' acquisition of Carson-Dellosa Publishing, LLC.
  • Represented Grotech Ventures II, L.P. and Harbert Venture Partners III, LP in a Series A venture capital investment into a Maryland-based health care technology company.
  • Represented private equity firm ABS Capital Partners in the recapitalization of Payformance Corporation.
  • Represented NewSpring Health Capital II, L.P.in a Series A investment into a Baltimore, Maryland-based health care services company.
  • Represented NewSpring SBIC Mezzanine Capital II, L.P. in acquiring controlling interest in Zentech Manufacturing, a Maryland-based manufacturing firm. The deal included 1) an asset purchase; 2) a senior bank loan; 3) a mezzanine subordinated debt loan to the company; and 4) a Series A preferred equity investment.

Mergers and Acquisitions

  • Represented Federal Data Systems in the acquisition of the counterintelligence and intelligence business unit of Intelligent Decisions for an undisclosed amount and in securing an equity investment from Chart Capital and senior bank financing to fund the acquisition.
  • Represented three Maryland companies that provide services in the insurance industry as brokers and third-party administrators and are part of the same corporate family-SF&C Insurance Associates, Inc., SF&C Select Benefits Communications Group, LLC, and Union Lifestyle Benefits, LLC, in their acquisition by U.S. Retirement Partners, Inc.
  • Represented Rohr International Dredge Holdings, Inc., a subsidiary of Ellicott Dredge Enterprises, in the acquisition of the assets of IDRECO GmbH .
  • Served as special government contracts' counsel for PharmAthene, Inc., a leading biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological terrorism in its $45 million acquisition of the vaccines business of Avecia Biologics Ltd., a privately owned company in Manchester, England.
  • Represented Syntec LLC in a Series A preferred stock capital raising transaction and in the purchase of a division of Tenax Corporation and subsequent sale to a public company three years later.
  • Represented the members of Ellicott Dredge Enterprises, LLC in the sale of a substantial portion of the membership interests to Markel Ventures, Inc.

REITS

  • Acted as Maryland co-counsel with Skadden Arps on corporate and litigation matters in defending Commonwealth REIT, a multi-billion dollar office REIT, in a hostile proxy fight initiated by Corvex Management LP and Related Fund Management LLC.